Alejandro Ibáñez‐Costa
Instituto Maimónides de Investigación Biomédica de Córdoba(ES)
Publications by Year
Research Areas
Pituitary Gland Disorders and Treatments, Neuroendocrine Tumor Research Advances, RNA Research and Splicing, Growth Hormone and Insulin-like Growth Factors, Systemic Lupus Erythematosus Research
Most-Cited Works
- → Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas(2015)89 cited
- → Ghrelin gene products, receptors, and GOAT enzyme: biological and pathophysiological insight(2013)86 cited
- → A Cellular and Molecular Basis for the Selective Desmopressin-Induced ACTH Release in Cushing Disease Patients: Key Role of AVPR1b Receptor and Potential Therapeutic Implications(2013)78 cited
- → Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity(2023)77 cited
- → Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro(2016)72 cited
- → In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features(2015)59 cited
- → Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug(2021)57 cited
- → E‐cadherin expression is associated with somatostatin analogue response in acromegaly(2019)52 cited
- → The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer(2017)51 cited
- → The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness(2017)50 cited